Editas Medicine Reports 58% HBG1/2 Promoter Editing in Non-Human Primates Using High Efficiency tLNP Delivery Method
12/6 08:10
Editas Medicine reports 58% mean editing in HSCs after single tLNP dose, aiding sickle cell and beta thalassemia treatments....